Details for Patent: 11,168,058
✉ Email this page to a colleague
Which drugs does patent 11,168,058 protect, and when does it expire?
Patent 11,168,058 protects NUBEQA and is included in one NDA.
This patent has fourteen patent family members in twelve countries.
Summary for Patent: 11,168,058
| Title: | Manufacture of a crystalline pharmaceutical product |
| Abstract: | The present disclosure relates to crystalline particles of N--((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-- hydroxyethyl)-1H-pyrazole-3-carboxamide (I) having specific surface area (SSA) in the range from about 8 to about 16 m.sup.2/g, preferably from about 10 to about 15 m.sup.2/g, and to the method for the preparation of such particles. Compound (I) is a potent androgen receptor (AR) modulator which is useful as a medicament for example in the treatment of prostate cancer. |
| Inventor(s): | Reunanen; Merja (Espoo, FI), Staffans; Anna (Espoo, FI) |
| Assignee: | ORION CORPORATION (Espoo, FI) |
| Application Number: | 16/491,642 |
|
Patent Claim Types: see list of patent claims | Compound; Process; Dosage form; |
Drugs Protected by US Patent 11,168,058
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare | NUBEQA | darolutamide | TABLET;ORAL | 212099-001 | Jul 30, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,168,058
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Finland | 20175202 | Mar 7, 2017 |
| PCT Information | |||
| PCT Filed | February 27, 2018 | PCT Application Number: | PCT/FI2018/050143 |
| PCT Publication Date: | September 13, 2018 | PCT Publication Number: | WO2018/162793 |
International Family Members for US Patent 11,168,058
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018229817 | ⤷ Try a Trial | |||
| Brazil | 112019018458 | ⤷ Try a Trial | |||
| Canada | 3055019 | ⤷ Try a Trial | |||
| Chile | 2019002540 | ⤷ Try a Trial | |||
| Chile | 2023002780 | ⤷ Try a Trial | |||
| China | 110382467 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 201992103 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
